{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:40:32Z","timestamp":1792676432960,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T00:00:00Z","timestamp":1459123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/nchembio.2050","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T18:52:46Z","timestamp":1459191166000},"page":"361-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":185,"title":["Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification"],"prefix":"10.1038","volume":"12","author":[{"given":"Richard M","family":"Deans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Morgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"\u00d6kesli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirika","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max A","family":"Horlbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3819-7019","authenticated-orcid":false,"given":"Martin","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E","family":"Carette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitan","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Bassik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"key":"BFnchembio2050_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","volume":"35","author":"Z Lou","year":"2014","unstructured":"Lou, Z., Sun, Y. & Rao, Z. Current progress in antiviral strategies. Trends Pharmacol. Sci. 35, 86\u2013102 (2014).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnchembio2050_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.coviro.2013.03.001","volume":"3","author":"Y Debing","year":"2013","unstructured":"Debing, Y., Jochmans, D. & Neyts, J. Intervention strategies for emerging viruses: use of antivirals. Curr. Opin. Virol. 3, 217\u2013224 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"BFnchembio2050_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2008.12.015","volume":"82","author":"R Harvey","year":"2009","unstructured":"Harvey, R. et al. GSK983: a novel compound with broad-spectrum antiviral activity. Antiviral Res. 82, 1\u201311 (2009).","journal-title":"Antiviral Res."},{"key":"BFnchembio2050_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.antiviral.2009.06.001","volume":"83","author":"MJ Aman","year":"2009","unstructured":"Aman, M.J. et al. Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Res. 83, 245\u2013251 (2009).","journal-title":"Antiviral Res."},{"key":"BFnchembio2050_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2011.10.011","volume":"93","author":"RG Panchal","year":"2012","unstructured":"Panchal, R.G. et al. Identification of an antioxidant small-molecule with broad-spectrum antiviral activity. Antiviral Res. 93, 23\u201329 (2012).","journal-title":"Antiviral Res."},{"key":"BFnchembio2050_CR6","first-page":"87","volume":"1","author":"MS Kinch","year":"2009","unstructured":"Kinch, M.S. et al. FGI-104: a broad-spectrum small molecule inhibitor of viral infection. Am. J. Transl. Res. 1, 87\u201398 (2009).","journal-title":"Am. J. Transl. Res."},{"key":"BFnchembio2050_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1073\/pnas.0307490100","volume":"101","author":"G Giaever","year":"2004","unstructured":"Giaever, G. et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. USA 101, 793\u2013798 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio2050_CR8","doi-asserted-by":"publisher","first-page":"11178","DOI":"10.1073\/pnas.1204524109","volume":"109","author":"E Gregori-Puigjan\u00e9","year":"2012","unstructured":"Gregori-Puigjan\u00e9, E. et al. Identifying mechanism-of-action targets for drugs and probes. Proc. Natl. Acad. Sci. USA 109, 11178\u201311183 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio2050_CR9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"BFnchembio2050_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cell.2006.06.040","volume":"126","author":"AB Parsons","year":"2006","unstructured":"Parsons, A.B. et al. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126, 611\u2013625 (2006).","journal-title":"Cell"},{"key":"BFnchembio2050_CR11","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1021\/cb3001028","volume":"7","author":"PM Petrone","year":"2012","unstructured":"Petrone, P.M. et al. Rethinking molecular similarity: comparing compounds on the basis of biological activity. ACS Chem. Biol. 7, 1399\u20131409 (2012).","journal-title":"ACS Chem. Biol."},{"key":"BFnchembio2050_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrg1836","volume":"7","author":"CJ Echeverri","year":"2006","unstructured":"Echeverri, C.J. & Perrimon, N. High-throughput RNAi screening in cultured cells: a user's guide. Nat. Rev. Genet. 7, 373\u2013384 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"BFnchembio2050_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nchembio.1199","volume":"9","author":"M Schenone","year":"2013","unstructured":"Schenone, M., Dan\u010d\u00edk, V., Wagner, B.K. & Clemons, P.A. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 9, 232\u2013240 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"BFnchembio2050_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.cell.2013.01.030","volume":"152","author":"MC Bassik","year":"2013","unstructured":"Bassik, M.C. et al. A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility. Cell 152, 909\u2013922 (2013).","journal-title":"Cell"},{"key":"BFnchembio2050_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nmeth.1330","volume":"6","author":"MC Bassik","year":"2009","unstructured":"Bassik, M.C. et al. Rapid creation and quantitative monitoring of high coverage shRNA libraries. Nat. Methods 6, 443\u2013445 (2009).","journal-title":"Nat. Methods"},{"key":"BFnchembio2050_CR16","doi-asserted-by":"publisher","first-page":"E2317","DOI":"10.1073\/pnas.1307002110","volume":"110","author":"M Kampmann","year":"2013","unstructured":"Kampmann, M., Bassik, M.C. & Weissman, J.S. Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells. Proc. Natl. Acad. Sci. USA 110, E2317\u2013E2326 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio2050_CR17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/nprot.2014.103","volume":"9","author":"M Kampmann","year":"2014","unstructured":"Kampmann, M., Bassik, M.C. & Weissman, J.S. Functional genomics platform for pooled screening and generation of mammalian genetic interaction maps. Nat. Protoc. 9, 1825\u20131847 (2014).","journal-title":"Nat. Protoc."},{"key":"BFnchembio2050_CR18","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.chembiol.2013.09.014","volume":"20","author":"CJ Matheny","year":"2013","unstructured":"Matheny, C.J. et al. Next-generation NAMPT inhibitors identified by sequential high-throughput phenotypic chemical and functional genomic screens. Chem. Biol. 20, 1352\u20131363 (2013).","journal-title":"Chem. Biol."},{"key":"BFnchembio2050_CR19","doi-asserted-by":"publisher","first-page":"e07314","DOI":"10.7554\/eLife.07314","volume":"4","author":"C Sidrauski","year":"2015","unstructured":"Sidrauski, C. et al. Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response. eLife 4, e07314 (2015).","journal-title":"eLife"},{"key":"BFnchembio2050_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"BFnchembio2050_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert, L.A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647\u2013661 (2014).","journal-title":"Cell"},{"key":"BFnchembio2050_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","volume":"154","author":"LA Gilbert","year":"2013","unstructured":"Gilbert, L.A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442\u2013451 (2013).","journal-title":"Cell"},{"key":"BFnchembio2050_CR23","doi-asserted-by":"publisher","first-page":"e00471","DOI":"10.7554\/eLife.00471","volume":"2","author":"M Jinek","year":"2013","unstructured":"Jinek, M. et al. RNA-programmed genome editing in human cells. eLife 2, e00471 (2013).","journal-title":"eLife"},{"key":"BFnchembio2050_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823\u2013826 (2013).","journal-title":"Science"},{"key":"BFnchembio2050_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84\u201387 (2014).","journal-title":"Science"},{"key":"BFnchembio2050_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.1246981","volume":"343","author":"T Wang","year":"2014","unstructured":"Wang, T., Wei, J.J., Sabatini, D.M. & Lander, E.S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80\u201384 (2014).","journal-title":"Science"},{"key":"BFnchembio2050_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1021\/op060223v","volume":"11","author":"SD Boggs","year":"2007","unstructured":"Boggs, S.D. et al. Efficient asymmetric synthesis of N-[(1R)-6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl]-2-pyridinecarboxamide for treatment of human papillomavirus infections. Org. Process Res. Dev. 11, 539\u2013545 (2007).","journal-title":"Org. Process Res. Dev."},{"key":"BFnchembio2050_CR28","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1016\/j.bmcl.2009.06.001","volume":"19","author":"KS Gudmundsson","year":"2009","unstructured":"Gudmundsson, K.S. et al. Tetrahydrocarbazole amides with potent activity against human papillomaviruses. Bioorg. Med. Chem. Lett. 19, 4110\u20134114 (2009).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnchembio2050_CR29","doi-asserted-by":"publisher","first-page":"E3384","DOI":"10.1073\/pnas.1508821112","volume":"112","author":"M Kampmann","year":"2015","unstructured":"Kampmann, M. et al. Next-generation libraries for robust RNA interference-based genome-wide screens. Proc. Natl. Acad. Sci. USA 112, E3384\u2013E3391 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio2050_CR30","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2013.12.001","volume":"155","author":"B Chen","year":"2013","unstructured":"Chen, B. et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR\/Cas system. Cell 155, 1479\u20131491 (2013).","journal-title":"Cell"},{"key":"BFnchembio2050_CR31","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.1232044","volume":"340","author":"L Bar-Peled","year":"2013","unstructured":"Bar-Peled, L. et al. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340, 1100\u20131106 (2013).","journal-title":"Science"},{"key":"BFnchembio2050_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.tcb.2014.03.003","volume":"24","author":"L Bar-Peled","year":"2014","unstructured":"Bar-Peled, L. & Sabatini, D.M. Regulation of mTORC1 by amino acids. Trends Cell Biol. 24, 400\u2013406 (2014).","journal-title":"Trends Cell Biol."},{"key":"BFnchembio2050_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0969-2126(00)00077-0","volume":"8","author":"S Liu","year":"2000","unstructured":"Liu, S., Neidhardt, E.A., Grossman, T.H., Ocain, T. & Clardy, J. Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure 8, 25\u201333 (2000).","journal-title":"Structure"},{"key":"BFnchembio2050_CR34","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.1228792","volume":"339","author":"I Ben-Sahra","year":"2013","unstructured":"Ben-Sahra, I., Howell, J.J., Asara, J.M. & Manning, B.D. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 339, 1323\u20131328 (2013).","journal-title":"Science"},{"key":"BFnchembio2050_CR35","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.1228771","volume":"339","author":"AM Robitaille","year":"2013","unstructured":"Robitaille, A.M. et al. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science 339, 1320\u20131323 (2013).","journal-title":"Science"},{"key":"BFnchembio2050_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E.Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"BFnchembio2050_CR37","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1021\/bi952168g","volume":"35","author":"JP Davis","year":"1996","unstructured":"Davis, J.P., Cain, G.A., Pitts, W.J., Magolda, R.L. & Copeland, R.A. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochemistry 35, 1270\u20131273 (1996).","journal-title":"Biochemistry"},{"key":"BFnchembio2050_CR38","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1073\/pnas.1101143108","volume":"108","author":"HH Hoffmann","year":"2011","unstructured":"Hoffmann, H.H., Kunz, A., Simon, V.A., Palese, P. & Shaw, M.L. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc. Natl. Acad. Sci. USA 108, 5777\u20135782 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio2050_CR39","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.1128\/JVI.02510-10","volume":"85","author":"QY Wang","year":"2011","unstructured":"Wang, Q.Y. et al. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. J. Virol. 85, 6548\u20136556 (2011).","journal-title":"J. Virol."},{"key":"BFnchembio2050_CR40","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.1073\/pnas.1017142108","volume":"108","author":"A Bonavia","year":"2011","unstructured":"Bonavia, A. et al. Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV). Proc. Natl. Acad. Sci. USA 108, 6739\u20136744 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio2050_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1006\/clim.1999.4777","volume":"93","author":"RI Fox","year":"1999","unstructured":"Fox, R.I. et al. Mechanism of action for leflunomide in rheumatoid arthritis. Clin. Immunol. 93, 198\u2013208 (1999).","journal-title":"Clin. Immunol."},{"key":"BFnchembio2050_CR42","doi-asserted-by":"publisher","first-page":"29682","DOI":"10.1074\/jbc.270.50.29690","volume":"270","author":"LD Fairbanks","year":"1995","unstructured":"Fairbanks, L.D., Bofill, M., Ruckemann, K. & Simmonds, H.A. Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors. J. Biol. Chem. 270, 29682\u201329689 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio2050_CR43","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1128\/AAC.00561-10","volume":"54","author":"M Qing","year":"2010","unstructured":"Qing, M. et al. Characterization of dengue virus resistance to brequinar in cell culture. Antimicrob. Agents Chemother. 54, 3686\u20133695 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio2050_CR44","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504\u2013507 (2013).","journal-title":"Nature"},{"key":"BFnchembio2050_CR45","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1046\/j.1432-1327.2001.02061.x","volume":"268","author":"A Ullrich","year":"2001","unstructured":"Ullrich, A., Knecht, W., Fries, M. & L\u00f6ffler, M. Recombinant expression of N-terminal truncated mutants of the membrane bound mouse, rat and human flavoenzyme dihydroorotate dehydrogenase. A versatile tool to rate inhibitor effects? Eur. J. Biochem. 268, 1861\u20131868 (2001).","journal-title":"Eur. J. Biochem."},{"key":"BFnchembio2050_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1006\/prep.1998.0925","volume":"13","author":"B Bader","year":"1998","unstructured":"Bader, B., Knecht, W., Fries, M. & L\u00f6ffler, M. Expression, purification, and characterization of histidine-tagged rat and human flavoenzyme dihydroorotate dehydrogenase. Protein Expr. Purif. 13, 414\u2013422 (1998).","journal-title":"Protein Expr. Purif."},{"key":"BFnchembio2050_CR47","doi-asserted-by":"publisher","first-page":"e1000632","DOI":"10.1371\/journal.ppat.1000632","volume":"5","author":"MM Samsa","year":"2009","unstructured":"Samsa, M.M. et al. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 5, e1000632 (2009).","journal-title":"PLoS Pathog."},{"key":"BFnchembio2050_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1006\/viro.1997.8500","volume":"230","author":"RM Kinney","year":"1997","unstructured":"Kinney, R.M. et al. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230, 300\u2013308 (1997).","journal-title":"Virology"},{"key":"BFnchembio2050_CR49","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.1128\/JVI.01151-10","volume":"84","author":"S Atasheva","year":"2010","unstructured":"Atasheva, S., Krendelchtchikova, V., Liopo, A., Frolova, E. & Frolov, I. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein. J. Virol. 84, 10004\u201310015 (2010).","journal-title":"J. Virol."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchembio.2050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.2050","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.2050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:41:44Z","timestamp":1684438904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.2050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFnchembio2050"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.2050","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]},"assertion":[{"value":"8 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stanford University has filed a patent application based on the findings in this report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}